{"transactions":[{"id":722011,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-07-01T20:35:01.000Z","date":"2026-07-01","kind":"grant","planned":false,"acquired":true,"shares":14858,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in two substantially equal annual installments beginning on July 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":232693,"source":{"system":"sec-edgar","filing":"0001193125-26-292685","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000119312526292685/ownership.xml","form_type":"4"}},{"id":807639,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-04-16T22:49:19.000Z","date":"2026-04-16","kind":"sale","planned":false,"acquired":false,"shares":11738,"price":7.02,"value":82400.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.02 to $7.05, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":217835,"source":{"system":"sec-edgar","filing":"0001193125-26-159579","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000119312526159579/ownership.xml","form_type":"4"}},{"id":870962,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T21:06:58.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":112661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2027 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":112661,"derivative":{"exercise_price":6.14,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":112661},"source":{"system":"sec-edgar","filing":"0001193125-26-088170","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000119312526088170/ownership.xml","form_type":"4"}},{"id":870961,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-03-03T21:06:58.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":62339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on January 15, 2027, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":229573,"source":{"system":"sec-edgar","filing":"0001193125-26-088170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000119312526088170/ownership.xml","form_type":"4"}},{"id":902395,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-18T00:48:18.000Z","date":"2026-02-17","kind":"sale","planned":false,"acquired":false,"shares":12079,"price":5.05,"value":60998.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.04 to $5.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":167234,"source":{"system":"sec-edgar","filing":"0001193125-26-055499","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000119312526055499/ownership.xml","form_type":"4"}},{"id":1171332,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-04-17T00:36:30.000Z","date":"2025-04-16","kind":"sale","planned":false,"acquired":false,"shares":7162,"price":5.49,"value":39319.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.48 to $5.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":179313,"source":{"system":"sec-edgar","filing":"0000950170-25-054953","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000095017025054953/ownership.xml","form_type":"4"}},{"id":1286015,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T22:51:35.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":59525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":59525,"derivative":{"exercise_price":7.68,"expiration_date":"2035-02-02","underlying":"Common Stock","underlying_shares":59525},"source":{"system":"sec-edgar","filing":"0000950170-25-013827","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000095017025013827/ownership.xml","form_type":"4"}},{"id":1286014,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-04T22:51:35.000Z","date":"2025-02-03","kind":"grant","planned":false,"acquired":true,"shares":90475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":186475,"source":{"system":"sec-edgar","filing":"0000950170-25-013827","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000095017025013827/ownership.xml","form_type":"4"}},{"id":1548144,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-04T20:10:06.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":144000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option vest as follows: 25% of the shares vest on April 1, 2025 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":144000,"derivative":{"exercise_price":7.4,"expiration_date":"2034-04-01","underlying":"Common Stock","underlying_shares":144000},"source":{"system":"sec-edgar","filing":"0000950170-24-041803","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000095017024041803/ownership.xml","form_type":"4"}},{"id":1548143,"issuer":{"id":5142,"kind":"organization","name":"Aura Biosciences, Inc."},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and Secretary"}}],"security":"Common Stock","published_at":"2024-04-04T20:10:06.000Z","date":"2024-04-02","kind":"grant","planned":false,"acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired pursuant to a restricted stock unit (\"RSU\") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on April 15, 2025, subject to the Reporting Person's continued service as of each such vesting date."}],"balance_after":96000,"source":{"system":"sec-edgar","filing":"0000950170-24-041803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000095017024041803/ownership.xml","form_type":"4"}},{"id":2822760,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:36:27.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":1848,"price":9.11,"value":16835.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 33.33% of the reporting person's restricted stock units granted on February 27, 2020."}],"balance_after":122336,"source":{"system":"sec-edgar","filing":"0001209191-21-016029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000120919121016029/doc4.xml","form_type":"4"}},{"id":2822759,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:36:27.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":2268,"price":9.11,"value":20661.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on January\n29, 2019."}],"balance_after":124184,"source":{"system":"sec-edgar","filing":"0001209191-21-016029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000120919121016029/doc4.xml","form_type":"4"}},{"id":2822758,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:36:27.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":1474,"price":9.11,"value":13428.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on March 15, 2018."}],"balance_after":126452,"source":{"system":"sec-edgar","filing":"0001209191-21-016029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000120919121016029/doc4.xml","form_type":"4"}},{"id":2822757,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Class A Common Stock","published_at":"2021-03-02T21:36:27.000Z","date":"2021-02-26","kind":"sale","acquired":false,"shares":1399,"price":9.11,"value":12744.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on February\n27, 2017."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person acquired 492 shares of Class A common stock under the issuer's employee stock purchase plan on December 31, 2020."}],"balance_after":127926,"source":{"system":"sec-edgar","filing":"0001209191-21-016029","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000120919121016029/doc4.xml","form_type":"4"}},{"id":2987171,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Class A Common Stock","published_at":"2020-11-10T21:09:05.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":237,"price":10.92,"value":2588.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on December 15, 2017."}],"balance_after":128833,"source":{"system":"sec-edgar","filing":"0001209191-20-057608","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000120919120057608/doc4.xml","form_type":"4"}},{"id":2987170,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Class A Common Stock","published_at":"2020-11-10T21:09:05.000Z","date":"2020-11-09","kind":"sale","acquired":false,"shares":599,"price":10.92,"value":6541.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on December 16, 2016."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The reporting person acquired 748 shares of Class A common stock under the issuer's employee stock purchase plan on June 30, 2020."}],"balance_after":129070,"source":{"system":"sec-edgar","filing":"0001209191-20-057608","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000120919120057608/doc4.xml","form_type":"4"}},{"id":3151519,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Class A Common Stock","published_at":"2020-05-13T21:19:49.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":558,"price":10.35,"value":5775.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding\nobligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on May 1,\n2019."}],"balance_after":128921,"source":{"system":"sec-edgar","filing":"0001209191-20-028895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000120919120028895/doc4.xml","form_type":"4"}},{"id":3151518,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Class A Common Stock","published_at":"2020-05-13T21:19:49.000Z","date":"2020-05-11","kind":"sale","acquired":false,"shares":158,"price":10.35,"value":1635.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding\nobligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on August 1,\n2016."}],"balance_after":129479,"source":{"system":"sec-edgar","filing":"0001209191-20-028895","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000120919120028895/doc4.xml","form_type":"4"}},{"id":3168594,"issuer":{"id":5213,"kind":"organization","name":"IRONWOOD PHARMACEUTICALS INC","symbol":"IRWD"},"owners":[{"id":34245,"kind":"person","name":"Kilroy Conor","position":1,"cik":"0001808510","reported_name":"Kilroy Conor","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, GC & Secretary"}}],"security":"Class A Common Stock","published_at":"2020-04-28T20:02:27.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":22814,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The restricted stock units, granted as a promotion award, vest as to approximately 33.33% of the shares of Class A Common Stock on each approximate anniversary of the grant thereof."}],"balance_after":129637,"source":{"system":"sec-edgar","filing":"0001209191-20-025917","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808510/000120919120025917/doc4.xml","form_type":"4"}}]}